GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » EV-to-EBIT

R1 RCM (R1 RCM) EV-to-EBIT : 59.74 (As of May. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is R1 RCM EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, R1 RCM's Enterprise Value is $7,300 Mil. R1 RCM's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $122 Mil. Therefore, R1 RCM's EV-to-EBIT for today is 59.74.

The historical rank and industry rank for R1 RCM's EV-to-EBIT or its related term are showing as below:

RCM' s EV-to-EBIT Range Over the Past 10 Years
Min: -2824.72   Med: 2.65   Max: 227.97
Current: 59.74

During the past 13 years, the highest EV-to-EBIT of R1 RCM was 227.97. The lowest was -2824.72. And the median was 2.65.

RCM's EV-to-EBIT is ranked worse than
91.82% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs RCM: 59.74

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. R1 RCM's Enterprise Value for the quarter that ended in Mar. 2024 was $7,631 Mil. R1 RCM's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $122 Mil. R1 RCM's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 1.60%.


R1 RCM EV-to-EBIT Historical Data

The historical data trend for R1 RCM's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM EV-to-EBIT Chart

R1 RCM Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.44 25.21 57.34 -2,273.59 40.62

R1 RCM Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -628.53 161.55 83.85 40.62 62.44

Competitive Comparison of R1 RCM's EV-to-EBIT

For the Health Information Services subindustry, R1 RCM's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


R1 RCM's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, R1 RCM's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where R1 RCM's EV-to-EBIT falls into.



R1 RCM EV-to-EBIT Calculation

R1 RCM's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7300.463/122.2
=59.74

R1 RCM's current Enterprise Value is $7,300 Mil.
R1 RCM's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $122 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


R1 RCM  (NAS:RCM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

R1 RCM's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=122.2/7630.7024
=1.60 %

R1 RCM's Enterprise Value for the quarter that ended in Mar. 2024 was $7,631 Mil.
R1 RCM's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $122 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


R1 RCM EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of R1 RCM's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


R1 RCM (R1 RCM) Business Description

Traded in Other Exchanges
Address
434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
Executives
Dominic Nakis director 433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr. officer: Principal Accounting Officer C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby officer: See Remarks C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas officer: President C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok officer: Chief Commercial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams officer: Chief Financial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade director C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp director, 10 percent owner 65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan director, officer: Chief Executive Officer C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean director R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long officer: See Remarks 7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner director 1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt director C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester director 311 ARSENAL STREET, WATERTOWN MA 02472